ZA961795B - Pharmaceuticals - Google Patents

Pharmaceuticals

Info

Publication number
ZA961795B
ZA961795B ZA961795A ZA961795A ZA961795B ZA 961795 B ZA961795 B ZA 961795B ZA 961795 A ZA961795 A ZA 961795A ZA 961795 A ZA961795 A ZA 961795A ZA 961795 B ZA961795 B ZA 961795B
Authority
ZA
South Africa
Prior art keywords
pharmaceuticals
bioprecursor
hhv
medicament
infection
Prior art date
Application number
ZA961795A
Other languages
English (en)
Inventor
Klaus Max Esser
Richard Anthony Vere Hodge
Original Assignee
Smithkline Beecham Plc
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc, Smithkline Beecham Corp filed Critical Smithkline Beecham Plc
Publication of ZA961795B publication Critical patent/ZA961795B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Transplantation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA961795A 1995-03-07 1996-03-05 Pharmaceuticals ZA961795B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9504497.0A GB9504497D0 (en) 1995-03-07 1995-03-07 Pharmaceuticals

Publications (1)

Publication Number Publication Date
ZA961795B true ZA961795B (en) 1996-11-25

Family

ID=10770731

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA961795A ZA961795B (en) 1995-03-07 1996-03-05 Pharmaceuticals

Country Status (23)

Country Link
US (1) US6489330B1 (hu)
EP (1) EP0814813B1 (hu)
JP (2) JPH11501625A (hu)
KR (1) KR19980702833A (hu)
CN (1) CN1138545C (hu)
AT (1) ATE254919T1 (hu)
AU (1) AU701739B2 (hu)
BR (1) BR9607663A (hu)
CA (1) CA2214406C (hu)
CY (1) CY2525B1 (hu)
CZ (1) CZ293470B6 (hu)
DE (1) DE69630876T2 (hu)
DK (1) DK0814813T3 (hu)
ES (1) ES2211949T3 (hu)
GB (1) GB9504497D0 (hu)
HK (1) HK1004373A1 (hu)
HU (1) HU226005B1 (hu)
NO (1) NO317733B1 (hu)
NZ (1) NZ303951A (hu)
PT (1) PT814813E (hu)
TR (1) TR199700921T1 (hu)
WO (1) WO1996027378A2 (hu)
ZA (1) ZA961795B (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료
WO2009126327A1 (en) * 2008-04-11 2009-10-15 Epiphany Biosciences, Inc. Treatment and/or prevention of multiple sclerosis
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0141927B1 (en) * 1983-08-18 1991-10-30 Beecham Group Plc Antiviral guanine derivatives
EP0182024B1 (en) * 1984-09-20 1991-04-03 Beecham Group Plc Purine derivatives and their pharmaceutical use
DE3671227D1 (de) * 1985-07-27 1990-06-21 Beecham Group Plc 9-substituierte guaninmonohydrate.
AU635642B2 (en) 1990-05-24 1993-03-25 E.R. Squibb & Sons, Inc. Fluorinated bis(hydroxymethyl) cyclobutyl purines and pyrimidines
GB9015051D0 (en) 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment

Also Published As

Publication number Publication date
HK1004373A1 (en) 1998-11-27
CA2214406A1 (en) 1996-09-12
CN1138545C (zh) 2004-02-18
CA2214406C (en) 2010-12-21
HUP9800272A2 (hu) 2000-05-28
ES2211949T3 (es) 2004-07-16
EP0814813A2 (en) 1998-01-07
HUP9800272A3 (en) 2000-12-28
US6489330B1 (en) 2002-12-03
GB9504497D0 (en) 1995-04-26
ATE254919T1 (de) 2003-12-15
PT814813E (pt) 2004-04-30
CY2525B1 (en) 2006-02-08
DE69630876T2 (de) 2004-09-02
MX9706759A (es) 1997-11-29
HU226005B1 (en) 2008-02-28
WO1996027378A3 (en) 1997-01-16
CN1183722A (zh) 1998-06-03
AU5102296A (en) 1996-09-23
CZ293470B6 (cs) 2004-05-12
DK0814813T3 (da) 2004-03-22
CZ283197A3 (cs) 1998-02-18
NO974101L (no) 1997-09-05
NO317733B1 (no) 2004-12-13
NZ303951A (en) 1999-07-29
WO1996027378A2 (en) 1996-09-12
DE69630876D1 (de) 2004-01-08
JP2007297412A (ja) 2007-11-15
EP0814813B1 (en) 2003-11-26
TR199700921T1 (xx) 1998-02-21
NO974101D0 (no) 1997-09-05
AU701739B2 (en) 1999-02-04
JPH11501625A (ja) 1999-02-09
KR19980702833A (ko) 1998-08-05
BR9607663A (pt) 1998-06-16

Similar Documents

Publication Publication Date Title
MX9707453A (es) Derivados de quinazolina.
ES2182852T3 (es) Derivados de prolinamida.
GEP20002298B (en) Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment
NZ308518A (en) Antibacterial cephalosporins
BR9506552A (pt) Método de inibição de integrase retroviral
PT736029E (pt) Sulfamatos de pseudofructopiranose anticonvulsivos
CY2525B1 (en) Use of penciclovir for the treatment of human herpes-virus-8
GB9323404D0 (en) Pharmaceuticals
CA2105385A1 (en) Treatment of cognitive disorders
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
GB9323403D0 (en) Pharmaceuticals
MX9709438A (es) Ester-amidas de acido 3-hidroxi-piridina-2-carboxilico, su preparacion y su utilizacion como medicamentos.